Solvay Loses False Advertising, Trademark Case
A federal jury in Minneapolis ruled in favor of KV and its generics subsidiary Ethex on Monday. A spokesman for the plaintiff said Tuesday that Solvay was still evaluating its options.
According to Solvay, Ethex falsely promoted its generic Pangestyme pancreatic enzyme products as bioequivalent versions of Solvay’s branded Creon microspheres.
Solvay accused the defendants of false advertising and unfair and deceptive trade practices....
To view the full article, register now.